Publication delay of randomized trials on 2009 influenza A (H1N1) vaccination.
Randomized evidence for vaccine immunogenicity and safety is urgently needed in the setting of pandemics with new emerging infectious agents. We carried out an observational survey to evaluate how many randomized controlled trials testing 2009 H1N1 vaccines were published among those registered, and...
Main Authors: | John P A Ioannidis, Lamberto Manzoli, Corrado De Vito, Maddalena D'Addario, Paolo Villari |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3229554?pdf=render |
Similar Items
-
Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.
by: Lamberto Manzoli, et al.
Published: (2011-01-01) -
Influenza A (H1N1) 2009 : To vaccinate or not to vaccinate?
by: Ali A Al-Jabri, et al.
Published: (2009-12-01) -
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine
by: Clark, Tristan, et al.
Published: (2009) -
Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials.
by: Raburn M Mallory, et al.
Published: (2010-10-01) -
Determinants of 2009 pandemic A/H1N1 influenza vaccination in Montreal
by: Brien, Stephanie
Published: (2012)